LeMaitre Vascular Inc (LMAT)
75.00
-0.90
(-1.19%)
USD |
NASDAQ |
May 08, 16:00
75.03
+0.03
(+0.04%)
After-Hours: 20:00
LeMaitre Vascular Enterprise Value: 1.595B for May 7, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 1.595B |
| May 06, 2024 | 1.575B |
| May 03, 2024 | 1.558B |
| May 02, 2024 | 1.390B |
| May 01, 2024 | 1.391B |
| April 30, 2024 | 1.346B |
| April 29, 2024 | 1.379B |
| April 26, 2024 | 1.361B |
| April 25, 2024 | 1.306B |
| April 24, 2024 | 1.329B |
| April 23, 2024 | 1.333B |
| April 22, 2024 | 1.301B |
| April 19, 2024 | 1.312B |
| April 18, 2024 | 1.297B |
| April 17, 2024 | 1.307B |
| April 16, 2024 | 1.331B |
| April 15, 2024 | 1.338B |
| April 12, 2024 | 1.343B |
| April 11, 2024 | 1.366B |
| April 10, 2024 | 1.397B |
| April 09, 2024 | 1.395B |
| April 08, 2024 | 1.355B |
| April 05, 2024 | 1.336B |
| April 04, 2024 | 1.320B |
| April 03, 2024 | 1.320B |
| Date | Value |
|---|---|
| April 02, 2024 | 1.326B |
| April 01, 2024 | 1.370B |
| March 31, 2024 | 1.378B |
| March 28, 2024 | 1.381B |
| March 27, 2024 | 1.400B |
| March 26, 2024 | 1.371B |
| March 25, 2024 | 1.359B |
| March 22, 2024 | 1.383B |
| March 21, 2024 | 1.403B |
| March 20, 2024 | 1.397B |
| March 19, 2024 | 1.397B |
| March 18, 2024 | 1.389B |
| March 15, 2024 | 1.392B |
| March 14, 2024 | 1.407B |
| March 13, 2024 | 1.387B |
| March 12, 2024 | 1.378B |
| March 11, 2024 | 1.346B |
| March 08, 2024 | 1.400B |
| March 07, 2024 | 1.432B |
| March 06, 2024 | 1.412B |
| March 05, 2024 | 1.405B |
| March 04, 2024 | 1.412B |
| March 01, 2024 | 1.404B |
| February 29, 2024 | 1.459B |
| February 28, 2024 | 1.482B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
391.67M
Minimum
Mar 23 2020
1.595B
Maximum
May 07 2024
927.04M
Average
964.46M
Median
Jan 23 2023
Enterprise Value Benchmarks
| Baxter International Inc | 28.98B |
| AtriCure Inc | 956.94M |
| Integer Holdings Corp | 4.889B |
| ICU Medical Inc | 3.828B |
| UFP Technologies Inc | 1.960B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 9.887M |
| Revenue (Quarterly) | 53.48M |
| Total Expenses (Quarterly) | 41.60M |
| EPS Diluted (Quarterly) | 0.44 |
| Gross Profit Margin (Quarterly) | 68.56% |
| Profit Margin (Quarterly) | 18.49% |
| Earnings Yield | 2.01% |
| Operating Earnings Yield | 2.42% |
| Normalized Earnings Yield | 2.005 |